Subtle Medical secured $33 million to accelerate its AI image enhancement solutions for radiology.
Key Details
- 1Subtle Medical raised $33 million in growth capital, bringing total funding to approximately $86 million.
- 2The funding was led by Morgan Stanley Expansion Capital, with participation from several new and existing investors.
- 3Subtle's AI solutions (SubtleHD(MR) for MRI, and SubtlePET for PET) speed up scan times while maintaining image quality.
- 4SubtlePET received FDA 510(k) clearance in May and can reduce PET scan times by up to 75%.
- 5The technology is deployed on about 1,300 scanners worldwide, across major institutions like Mount Sinai and RadNet.
Why It Matters
Expanded funding allows Subtle Medical to further develop and deploy its vendor-neutral AI solutions, enhancing efficiency and patient throughput across radiology departments globally. Rapid scan times and improved imaging quality are key benefits for healthcare providers adopting AI technologies.
Source
Radiology Business
Related News
•AuntMinnie
In-House LLM Accurately Flags Critical Pediatric Radiology Findings
A locally deployed LLM system at Stanford Health achieved 99.7% sensitivity for detecting critical results in pediatric radiology reports, supporting workflow automation.
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.
•Radiology Business
FDA Approves SimBioSys AI Tool for Breast Cancer Risk via MRI
SimBioSys received FDA clearance for TumorSight Risk, an AI tool assessing breast cancer recurrence risk using MRI.